×

New initiative to support MS treatment decisions in older adults

The Accelerated Cure Project for Multiple Sclerosis (ACP) has received funding to help interpret and share findings from the DISCO-MS study, which examined whether older adults with stable multiple sclerosis (MS) could stop disease-modifying medications, to support more informed treatment decisions. The award comes through…

Age plays role in how RRMS affects brain volume over time

Brain atrophy, or the loss of brain volume, in people with relapsing-remitting multiple sclerosis (RRMS) appears to slow with age, according to data from more than 4,000 patients who took part in Phase 3 clinical trials. Researchers found that older adults with RRMS had significantly…

If your older are you going to be wanted in Trials

Tweet Drug development is ageist and if you are over a certain age you may be excluded from trials. This study looks at relapsing remitting trials and says that if they examine older people they may need more people to detect a different. This study…

A columnist’s perspective on adaptation and humor with MS

In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…

Neurologist Kappos wins Dystel Prize for advancing MS research

Ludwig Kappos, MD, a neurologist and researcher at University Hospital in Basel, Switzerland, has been named the 2026 recipient of the John Dystel Prize for Multiple Sclerosis Research for his central role in advancing understanding and treatment of multiple sclerosis (MS) and monitoring of disease…